quick search
Today:
Home Manufacturing

More Articles

Huawei Cloud CVADCS Unveils Revolutionary Solutions for Smart Mining at MWC 2025

Mar 5, 2025

BARCELONA,Spain,March 3,2025-- Huawei Cloud Commercial Vehicle Autonomous Driving Cloud Service (CVADCS) is thrilled to announce its debut at the Mobile World Congress (MWC) 2025,showcasing pioneering

Liberty Mutual Insurance Agrees to Sell Thailand and Vietnam Operations to Chubb

Mar 5, 2025

Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit

Link to the Future, Anytime, Anywhere Realizing High Resilience Showcases Cutting-Edge Solutions at MWC 2025

Mar 5, 2025

BARCELONA,Spain,March 3,2025-- D-Link Corporation (TWSE: 2332),a global leader in networking solutions,is set to reinforce its leadership and innovation at the 2025 Mobile World Congress (MWC) in Barc

HONOR Unveils New Corporate Strategy to Transition to an AI Device Ecosystem Company

Mar 5, 2025

Illuminating a three-step roadmap underpinned by openness and collaboration BARCELONA,Spain,March 3,2025-- Global technology brand HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy

Addentax Group Corp. Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Mar 5, 2025

SHENZHEN,China,March 3,2025-- Addentax Group Corp. ("Addentax" or the "Company") (Nasdaq: ATXG) announced that it has regained compliance with the Nasdaq Listing Rule 5450(a)(1).

Huawei's Yang Chaobin: AI-Centric Network Solution Helps Carriers Seize AI Opportunities

Mar 5, 2025

BARCELONA,Spain,March 3,2025-- At the Huawei Product & Solution Launch during MWC Barcelona 2025,Yang Chaobin,Huawei\'s Director of the Board and CEO of the ICT Business Group,launched the company

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

Mar 5, 2025

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]

Leading French operators join Aduna as network partners to open network APIs to the market

Mar 5, 2025

STOCKHOLM,March 4,2025-- Aduna,a landmark venture between some of the world\'s leading telecom operators and Ericsson,today announced that,in a significant move for the telecom industry,two of France\

FiberHome Shines at MWC 2025: Pioneering a Bright Digital Future

Mar 5, 2025

BARCELONA,Spain,March 4,2025-- The global spotlight turned to the 2025 World Mobile Communications Congress (MWC),where FiberHome made a dazzling appearance under the theme "Connecting the Bright

Viettel Brings Vietnamese Technology to the World's Largest Mobile Industry Event

Mar 5, 2025

BARCELONA,Spain,March 4,2025-- At MWC Barcelona 2025,ViettelGroup showcases a series of cutting-edge Vietnamese technological innovations. A total of 22 products developed by Viettel span across key d

1 ... 17 18 19 20 21 22 23 ... 133

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs